Home | Doctors | Dr Sharat Chandra Goteti

Dr Sharat Chandra Goteti

MBBS, DNB - General Medicine, DrNB Medical Oncology, MRCP (UK) - Medical Oncology (SCE) , European Board Certified Medical Oncology - ECMO
Consultant Medical and Hemato Oncology
Experience: 5 Years
Location: Hyderabad


About Doctor:

  • Breast Cancer
  • Lung Cancer
  • Gastro Intestinal Cancers
  • Head and Neck Cancer
  • Genito Urinary cancers
  • Hematological Malignancies
  • Bone cancer and soft tissue sarcomas
  • Targeted Therapy
  • Immuno Therapy
  • Palliative & Supportive Care for Advanced Cancer
  • Bone Marrow Aspiration and Biopsy
  • Lumbar puncture and Intrathecal therapy
  • Hereditary cancers – Screening and genetic counselling
  • Precision Oncology
  • Familial and hereditary cancer treatment
  • Cancer screening with genetic counselling
  • Senior Registrar in Medical Oncology in Apollo Indraprastha Hospitals in Delhi NCR – 3 years
  • Senior Resident in Medical Oncology in at P D Hinduja National Hospitals and Research Center, Mumbai ,Maharastra– 1 year
  • Membership of Royal College of Physicians of United Kingdom in Medical Oncology - MRCP (UK) - Speciality Certificate Examination -2021
  • Doctorate of National Board - Medical Oncology - Apollo Indraprastha Hospitals and Research Center, New Delhi
  • Diplomat of National Board - General Medicine - P.D.Hinduja National Hospitals and Research Center, Mumbai
  • MBBS - Bhaskar Medical College and Research Center, Hyderabad
  • Merit Award by European Society Of Medical Oncology- Immuno Oncology Conference At Geneva, Switzerland 2020 (Virtual) For Best Abstract
  • Travel Grant by European Society of Medical Oncology- Immuno Oncology Preceptorship, Singapore, November 2019
  • 2nd Prize in Quiz competition at Best of SABCS, New Delhi ,March 2020
  • 1st Prize at Oncology Quiz at Delhi Breast oncology Group (DBOG) meeting, May 2019, New Delhi
  • 2nd Prize in Oncology Quiz competition at Best of WCLC, November 2019, New Delhi
  • 3rd Prize in the Oncology Quiz organized by Max Institute of Oncology in March 2019
  • Pathological response to weekly nabpaclitaxel and carboplatin followed by anthracycline regimen in triple negative breast cancer – ANNALS OF ONCOLOGY, Volume 31, Supplement 6, November 2020, Page S1253 G.Sharat Chandra, M.Singhal, D.Panda, A.Sharma,S.Valame - https://doi.org/10.1016/j.annonc.2020.10.055
  • Shortcomings of immuno oncology (IO) agents application into real-world practise due to financial constraints in a resource constrained setting - ANNALS OF ONCOLOGY, Volume 31, Supplement 7, December 2020, Page S1436. G.Sharat Chandra, M.Singhal,A.Sharma, S.Valame - https://doi.org/10.1016/j.annonc.2020.10.538
  • Real-world data of incidence of immune related toxicities with single agent immuno oncology drugs at a single center - ANNALS OF ONCOLOGY, Volume 31, Supplement 7, December 2020, Page S1439 G.Sharat Chandra, M.Singhal, D.Panda, A.Sharma,S.Valame - https://doi.org/10.1016/j.annonc.2020.10.545
  • A Prospective Study of Response Evaluation with RCHOP Therapy in DLBCL Subtypes using Hans Algorithm - Indian J Hematol Blood Transfusion (Nov 2020) 36(Suppl 1):S1–S229. Sharat Chandra G, Pratap Kishore Das,Manish singhal, Dipanjanpanda, Atul Sharma, ShaunakValame, Amarendra Amar, Jayantpatowary - https://doi.org/10.1007/s12288-020-01384-8
  • A real-world scenario of applicability of immuno oncology agents into practice in NSCLC in a resource constrained setting – JOURNAL OF THORACIC ONCOLOGY, Vol. 16Issue 4S767–S768Published in issue: April, 2021. G.Sharat Chandra, M.Singhal,A.Sharma, S.Valame - https://doi.org/10.1016/S1556-0864(21)01970-5
  • Primary thyroid lymphoma – A case report and its review of literature , Jan 2019 , Apollo Medicine
  • Oral mucositis with abiraterone acetate – a therapeutic dilemma , December 2019 , Indian journal of medical and pediatric oncology
  • English
  • తెలుగు
  • हिन्दी